FDA Approves Antiviral Remdesivir to Treat COVID-19
The FDA has approved the very first treatment for COVID-19, and the drugmaker has donated their “entire supply.”
May 1, 2020
Phase III Clinical Trial of Hydroxychloroquine to Begin
The drug President Trump has often touted as a treatment for COVID-19, despite it being, as yet, unproven, is set to begin a Phase III clinical trial.
April 21, 2020
Trump Pressures Pharma Companies for Coronavirus Vaccine
Executives from some of the world’s largest pharmaceutical and biotechnology companies met with President Trump to discuss the timeline of a coronavirus vaccine.
March 5, 2020
Top Paying States for Popular BioPharma Roles
Where are you most valued? We’ve ranked the states offering the most generous average annual salaries for nine popular roles within biopharma.
January 28, 2020
FDA Task Force Releases Report on Drug Shortages
A report from the FDA’s Drug Shortages Task Force has found that there is no one single cause for drug shortages, nor an easy solution to stop them.
November 6, 2019
Mylan to Pay SEC $30M over EpiPen Pricing
The EpiPen drug maker has reached a settlement over a lawsuit with the Securities and Exchange Commission.
September 29, 2019
Congress Rakes In Millions From Drugmakers
Members of Congress received almost $4 million from pharmaceutical manufacturers and their trade groups in the first half of 2019.
September 20, 2019
Americans Rank Pharma Industry as Least Favorable
According to a new poll, even the U.S. federal government is more well-liked by Americans than the pharmaceutical industry.
September 18, 2019
Oklahoma’s ‘Precedent-Setting’ Suit Puts Opioid Drugmakers On Trial
All eyes were on Oklahoma last week, when the first case in a flood of litigation against opioid drug manufacturers began Tuesday.
June 3, 2019
Heart Drug Spotlights Troubling Trends In Drug Marketing
Headlines proclaimed a potential game changer in treating cardiovascular disease—Vascepa—and company shares quickly soared, but the study behind the claim remains a mystery.
November 7, 2018